Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98

Alcon Research

Overview

The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Open-Angle Glaucoma Ocular Hypertension

Interventions

IOP Lowering MedicationsDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Adults of Japanese Ethnicity

Locations (3)

Unnamed facility

Los Angeles, California, United States

Unnamed facility

San Francisco, California, United States

Unnamed facility

Honolulu, Hawaii, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.